ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

KENNETH SCHAEFER MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,165Medicare Part D Prescriptions Filled, Including Refills

Rank: 84 out of 910

$661K Total Retail Price of All Prescriptions

Rank: 85 out of 910

629 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 629 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

8% of this provider’s 629 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,732 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 650 631 1 1
SIMVASTATIN 512 490 2 3
LISINOPRIL 393 377 3 2
AMLODIPINE BESYLATE 311 303 4 4
OMEPRAZOLE 303 282 5 5
WARFARIN SODIUM 300 295 6 11
FUROSEMIDE 262 261 7 9
ZOLPIDEM TARTRATE 253 239 8 17
METOPROLOL TARTRATE 227 223 9 7
HYDROCODONE-ACETAMINOPHEN 193 182 S3 10 8
METOPROLOL SUCCINATE 191 187 11 21
PANTOPRAZOLE SODIUM 183 172 12 27
ATENOLOL 179 175 13 10
METFORMIN HCL 160 157 14 6
CITALOPRAM HBR 152 141 15 19
POTASSIUM CHLORIDE 146 144 16 18
TRAMADOL HCL 137 133 17 25
HYDROCHLOROTHIAZIDE 133 121 18 12
CLOPIDOGREL 133 125 18 35
GABAPENTIN 126 117 20 13
TAMSULOSIN HCL 116 116 21 29
DONEPEZIL HCL 114 110 22 32
CRESTOR 111 111 23 26
ALLOPURINOL 107 107 24 33
CARVEDILOL 100 100 25 36
DOXAZOSIN MESYLATE 98 96 26 62
GLIMEPIRIDE 97 92 27 56
TERAZOSIN HCL 93 93 28 61
FLUTICASONE PROPIONATE 92 91 29 23
PAROXETINE HCL 92 77 29 50
ALPRAZOLAM 89 83 31 172
OXYBUTYNIN CHLORIDE ER 87 87 32 111
PLAVIX 86 81 33 53
ALENDRONATE SODIUM 85 85 34 22
HYDRALAZINE HCL 82 82 35 65
DIGOXIN 79 79 36 64
PREDNISONE 77 63 37 43
NAMENDA 77 77 37 57
OXYCODONE-ACETAMINOPHEN 76 74 S2 39 31
TRIAMTERENE-HCTZ 70 67 40 39
CIPROFLOXACIN HCL 68 65 41 48
POLYETHYLENE GLYCOL 3350 65 63 42 104
FINASTERIDE 64 64 43 59
CELEBREX 63 62 44 85
NAPROXEN 63 63 44 96
JANUVIA 62 62 46 69
LOSARTAN POTASSIUM 59 59 47 15
VERAPAMIL ER 59 59 47 99
DICLOFENAC SODIUM 57 57 49 116
LORAZEPAM 55 55 50 151
ACTOS 55 55 50 86
ISOSORBIDE MONONITRATE ER 54 54 52 81
LOVASTATIN 54 54 52 20
METHYLPREDNISOLONE 54 53 52 122
CLONIDINE HCL 53 50 55 51
ADVAIR DISKUS 53 53 55 45
DILTIAZEM 24HR ER 51 51 57 244
TEMAZEPAM 51 51 57 384
RANITIDINE HCL 50 50 59 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.